SCHEMBL4755898

SCHEMBL4755898

Cc1ccc(O)c(C(=O)Nc2ncc(S(C)(=O)=O)s2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STAT3 P40763 4/20 0.63
GRM5 P41594 1/20 0.46
FFAR2 O15552 1/20 0.44
P2RX1 P51575 1/20 0.43
TMPRSS4 Q9NRS4 1/20 0.43
PLAU P00749 2/20 0.43
F2 P00734 1/20 0.43
F10 P00742 1/20 0.43
PLAT P00750 1/20 0.43
KCNMA1 Q12791 1/20 0.40
CSNK2A1 P68400 1/20 0.40
FBP1 P09467 1/20 0.40
MEN1 O00255 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
KMT2A Q03164 3/20 0.39
PKM P14618 1/20 0.39
CRHBP P24387 1/20 0.39
CRHR2 Q13324 1/20 0.39
ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4755924 0.90 STAT3 (0.63) STAT3FFAR2PLAUF2F10
SCHEMBL4755857 0.87 STAT3 (0.47) STAT3FFAR2FBP1MEN1NPC1
SCHEMBL4757157 0.86 STAT3 (0.49) STAT3FFAR2FBP1MEN1NPC1
SCHEMBL4757189 0.84 FFAR2 (0.48) STAT3FFAR2MEN1NPC1RAB9A
SCHEMBL31426452 0.84 STAT3 (0.58) STAT3FFAR2MEN1NPC1RAB9A
SCHEMBL704075 0.84 STAT3 (0.58) STAT3FFAR2MEN1NPC1RAB9A
SCHEMBL3893328 0.81 STAT3 (0.67) STAT3GRM5FFAR2P2RX1TMPRSS4
SCHEMBL14380922 0.81 STAT3 (0.67) STAT3GRM5P2RX1TMPRSS4PLAU
SCHEMBL4757155 0.81 NPC1 (0.59) FFAR2MEN1NPC1RAB9AKMT2A
SCHEMBL4756867 0.81 STAT3 (0.46) STAT3FFAR2MEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-8895752-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES L.C. (US) 2014-11-25 US disclosed
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES, L.C. 2012-05-17 US disclosed
US-8124632-B2 Alkylsulfonyl-substituted thiazolide compounds ROMARK LABORATORIES, L.C. (US) 2012-02-28 US disclosed
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS ROMARK LABORATORIES L.C. 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122939-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885GRM5 4521/4885FFAR2 4045/4885
US-20090036467-A1 ALKYLSULFONYL-SUBSTITUTED THIAZOLIDE COMPOUNDS HAVCR2, EIF2AK2, AADAC STAT3 63/4885GRM5 4521/4885FFAR2 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.